Skip to main content
. 2019 Nov 20;2019(11):CD003511. doi: 10.1002/14651858.CD003511.pub5

Summary of findings for the main comparison. Progestogen compared to placebo/no treatment for preventing miscarriage in women with recurrent miscarriage of unclear etiology.

Progestogen compared to placebo/no treatment for preventing miscarriage in women with recurrent miscarriage of unclear etiology
Patient or population: women with recurrent miscarriage of unclear etiology
 Setting: mix of multicenter and single‐center trials based in Egypt, India, Jordan, UK and USA
Intervention: progestogen
 Comparison: placebo/no treatment
Outcomes Anticipated absolute effects* (95% CI) Relative effect
 (95% CI) № of participants
 (studies) Certainty of the evidence
 (GRADE) Comments
Risk with placebo/no treatment Risk with progestogen
Miscarriage (all trials) Study population average RR 0.73
 (0.54 to 1.00) 1684
 (10 RCTs) ⊕⊕⊕⊝
Moderate1
 
275 per 1000 201 per 1000
 (149 to 275)
Live birth rate Study population RR 1.07
 (1.00 to 1.13) 1411
 (6 RCTs) ⊕⊕⊕⊝
Moderate1
 
701 per 1000 750 per 1000
 (701 to 793)
Preterm birth Study population RR 1.13
 (0.53 to 2.41) 256
 (4 RCTs) ⊕⊝⊝⊝
 Very low1,2  
75 per 1000 84 per 1000
 (40 to 180)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 
 CI: confidence interval; RCT: randomized controlled trial; RR: risk ratio
GRADE Working Group grades of evidenceHigh certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
 Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
 Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
 Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

1 We downgraded (1) level for serious limitations in study design due to some of the studies being at high or unclear risk for selection bias.

2 We downgraded (2) levels for very serious limitations in imprecision due to small number of events, small sample size and wide CI crossing the line of no effect.